Mdma: Research Areas Needing More Emphasis
The summary for the Mdma: Research Areas Needing More Emphasis grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Mdma: Research Areas Needing More Emphasis: The purpose of this PA is to provide an optimally comprehensive, strategic, and balanced MDMA (3,4-methylenedioxymethamphetamine) research program, given the upsurge in MDMA abuse worldwide, including its abuse outside the rave scene. Although researchers have made great strides in characterizing MDMAs neural mechanisms and neurotoxicity, it is necessary now to focus on specific areas of MDMA research, across all research disciplines, urgently needing our attention. For the purpose of this PA, the term MDMA is defined as 3,4-methylenedioxymethamphetamine and its very close structural analogues, such as p-methoxyamphetamine (PMA), p-methoxymethamphetamine (PMMA), and 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA), insofar as they share specific subjective, discriminative stimulus, or toxicological properties with 3,4-methylenedioxymethamphetamine; however, methamphetamine and other amphetamines that are characterized by neurotoxic effects on central dopaminergic systems in experimental animals are not included in this definition. Ecstasy is defined as a preparation (usually a tablet) supposed by its users to contain MDMA.
|Federal Grant Title:||Mdma: Research Areas Needing More Emphasis|
|Federal Agency Name:||National Institutes of Health|
|Grant Categories:||Health Education|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||PA-04-152|
|Type of Funding:||Grant|
|CFDA Descriptions:||Drug Abuse Research Programs|
|Current Application Deadline:||No deadline provided|
|Original Application Deadline:||Multiple Receipt Dates - See Link to Full Announce|
|Posted Date:||Sep 08, 2004|
|Creation Date:||Dec 07, 2006|
|Archive Date:||Feb 03, 2007|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- Small businesses Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education City or township governments For profit organizations other than small businesses Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Others (see text field entitled "Additional Information on Eligibility" for clarification) County governments Native American tribal organizations (other than Federally recognized tribal governments) State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Independent school districts
- Additional Information on Eligibility
- Eligible agencies of the Federal Government are eligible to apply. Foreign institutions are eligible to apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
- Similar Government Grants
- • Nicotinic Immune Modulation in the Presence of HIV-1 Infection (R01)
- • Hepatitis C Virus (HCV) Advanced Molecular Detection in Support of Systems for Prevention,...
- • Drug Abuse Dissertation Research (R36)
- • Encouraging Appropriate Care Using Behavioral Economics through Electronic Health Records ...
- • Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01)
- • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
- • Drug Abuse Aspects of Hiv/Aids and Other Infections
- • Epidemiology of Drug Abuse
- More Grants from the National Institutes of Health
- • BRAIN Initiative: Exploratory Targeted BRAIN Circuits Projects - eTargetedBCP (R21)
- • BRAIN Initiative: Targeted BRAIN Circuits Projects - TargetedBCP (R01)
- • Tools for Clinical Care and Management of Alzheimers Disease (AD) and its Comorbidities (R...
- • Tools for Clinical Care and Management of Alzheimers Disease (AD) and Its Comorbidities (R...
- • Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (...